Hypnotic drugs, psychomotor performance and ageing
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
SUMMARY This review examines studies, reported since 1976, in which the residual effects of hypnotic drugs on psychomotor performance have been evaluated in older people. The 33 studies involved a total of 934 subjects (aged 60–96 y), evaluated 21 different products, utilized 26 test procedures, and reported 169 drug versus placebo (or drug versus drug) comparisons, of which 42 were associated with significant residual impairment. While performance decrements were more associated with longer half‐life drugs, repeated dosing, and frailty, these characteristics were often unreliable in predicting outcome. Significant improvements in performance were rare, and usually consistent with practice effects. While this literature provides a useful basis for clinical caution, it is not characterized by experimental rigour, and provides little or no empirical basis for predicting those real‐life skills most likely to be affected. Issues of subject selection, experimental design, testing strategies, and data analysis need to be addressed if the risks and benefits of hypnotic drug use in later life are to be more clearly understood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benzodiazepines: use, abuse, and consequences.
Woods, J. H., Katz, J. L., & Winger, G. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00468-5 · Cited by 560
Increased sensitivity to nitrazepam in old age
Castleden, C. M., George, C. F., Marcer, D., & Hallett, C. (1977) · BMJ · doi:10.1136/bmj.1.6052.10 · Cited by 320
Sensitivity to triazolam in the elderly
Greenblatt, D. J., Harmatz, J. S., Shapiro, L., Engelhardt, N., Gouthro, T. A., & Shader, R. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242403 · Cited by 258
Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.1.121 · Cited by 152
Nitrazepam: lastingly effective but trouble on withdrawal.
Adam, K., Adamson, L., Brezinova, V, & Hunter, W. M. (1976) · BMJ · doi:10.1136/bmj.1.6025.1558 · Cited by 90
Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing
Kroboth, P. D., McAuley, J. W., & Smith, R. B. (1990) · Psychopharmacology · doi:10.1007/bf02243999 · Cited by 35
Cited by
Psychobiology of Altered States of Consciousness.
Vaitl, D., Birbaumer, N., Gruzelier, J., Jamieson, G. A., Kotchoubey, B., Kübler, A., Lehmann, D., Miltner, W. H. R., Ott, U., Pütz, P., et al. (2005) · Psychological Bulletin · doi:10.1037/0033-2909.131.1.98 · Cited by 448
Sleep and morningness‐eveningness in the ‘middle’ years of life (20–59y)
CARRIER, J., MONK, T. H., BUYSSE, D. J., & KUPFER, D. J. (1997) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1997.00230.x · Cited by 303
CURRAN, H. V., COLLINS, R., FLETCHER, S., KEE, S. C. Y., WOODS, B., & ILIFFE, S. (2003) · Psychological Medicine · doi:10.1017/s0033291703008213 · Cited by 190
“Residual effects on daytime performance following single or several night-time doses have also been documented in older people (Morgan, 1994).”
BackgroundInfluentialChronic hypnotic use: deadly risks, doubtful benefit
Kripke, D. F. (2000) · Sleep Medicine Reviews · doi:10.1053/smrv.1999.0076 · Cited by 147
Metadata
- Authors
- MORGAN, K.
- Venue
- Journal of Sleep Research
- Publisher
- Wiley
- Published
- 1994-03
- Volume
- 3
- Issue
- 1
- Pages
- 1-15
- ISSN
- 0962-1105 (ISSN-L)
- 1365-2869
- OpenAlex
- W2036261850
- Cited by
- 18
- References
- 6
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypnotic drugs, psychomotor performance and ageing. https://app.cochat.ai/papers/10.1111/j.1365-2869.1994.tb00098.x
- The paper
- MORGAN, K. (1994). Hypnotic drugs, psychomotor performance and ageing. Journal of Sleep Research. https://doi.org/10.1111/j.1365-2869.1994.tb00098.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.